InvestorsHub Logo
Followers 1
Posts 287
Boards Moderated 0
Alias Born 03/14/2016

Re: plusorminus post# 63281

Wednesday, 02/08/2017 11:48:33 AM

Wednesday, February 08, 2017 11:48:33 AM

Post# of 144814
No need for a 3-year trial because patients won't be living that long. These are patients with advanced inoperable cancer that has stopped responding to standard of care. A 2- or 3-month gain in overall survival would be a major win.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News